|
Neoplasms
|
0.030 |
Biomarker
|
group |
BEFREE |
CRIP1 (cysteine-rich intestinal protein 1) has been found in several tumor types, its prognostic impact and its role in cellular processes, particularly in breast cancer, are still unclear.
|
23570421 |
2013 |
|
Neoplasms
|
0.030 |
Biomarker
|
group |
BEFREE |
A candidate tumor-suppressor gene, cysteine-rich intestinal protein 2 (CRIP2), located in the hot spot for chromosomal loss at 14q32.3, was identified as an important candidate gene capable of functionally suppressing tumor formation.
|
21540330 |
2011 |
|
Neoplasms
|
0.030 |
Biomarker
|
group |
BEFREE |
Seven days after the graft, packaging cells (psi CRIP-TK and psi CRIP-LLZ) were inoculated into tumor mass, followed by GCV administration.
|
10226527 |
1999 |
|
Colorectal Carcinoma
|
0.020 |
Biomarker
|
disease |
BEFREE |
Cysteine-rich intestinal protein 1 suppresses apoptosis and chemosensitivity to 5-fluorouracil in colorectal cancer through ubiquitin-mediated Fas degradation.
|
30850009 |
2019 |
|
Malignant neoplasm of colon and/or rectum
|
0.020 |
Biomarker
|
disease |
BEFREE |
Cysteine-rich intestinal protein 1 suppresses apoptosis and chemosensitivity to 5-fluorouracil in colorectal cancer through ubiquitin-mediated Fas degradation.
|
30850009 |
2019 |
|
Colorectal Carcinoma
|
0.020 |
Biomarker
|
disease |
BEFREE |
Cysteine-Rich Intestinal Protein 1 Silencing Inhibits Migration and Invasion in Human Colorectal Cancer.
|
29179181 |
2017 |
|
Tumor Cell Invasion
|
0.020 |
Biomarker
|
phenotype |
BEFREE |
Cysteine-Rich Intestinal Protein 1 Silencing Inhibits Migration and Invasion in Human Colorectal Cancer.
|
29179181 |
2017 |
|
Malignant neoplasm of colon and/or rectum
|
0.020 |
Biomarker
|
disease |
BEFREE |
Cysteine-Rich Intestinal Protein 1 Silencing Inhibits Migration and Invasion in Human Colorectal Cancer.
|
29179181 |
2017 |
|
Tumor Cell Invasion
|
0.020 |
Biomarker
|
phenotype |
BEFREE |
MDA-MB-231 cells stably transfected with CRIP2 demonstrated a significant reduction in cell viability, migration, and invasion, as well as decreased tumor growth and angiogenesis in mouse xenograft models.
|
26934316 |
2016 |
|
Malignant neoplasm of breast
|
0.020 |
Biomarker
|
disease |
BEFREE |
CRIP1 (cysteine-rich intestinal protein 1) has been found in several tumor types, its prognostic impact and its role in cellular processes, particularly in breast cancer, are still unclear.
|
23570421 |
2013 |
|
Breast Carcinoma
|
0.020 |
Biomarker
|
disease |
BEFREE |
CRIP1 (cysteine-rich intestinal protein 1) has been found in several tumor types, its prognostic impact and its role in cellular processes, particularly in breast cancer, are still unclear.
|
23570421 |
2013 |
|
Carcinogenesis
|
0.020 |
Biomarker
|
phenotype |
BEFREE |
The group 2 LIM domain protein, Cysteine-rich intestinal protein 2 (CRIP2) was found to play an important role in esophageal squamous cell carcinoma (ESCC) tumorigenesis.
|
22154084 |
2012 |
|
Carcinogenesis
|
0.020 |
Biomarker
|
phenotype |
BEFREE |
CRIP2 reexpression functionally suppresses in vivo tumorigenesis and angiogenesis; these effects are induced by its transcription-repressor capability.
|
21540330 |
2011 |
|
Malignant neoplasm of breast
|
0.020 |
Biomarker
|
disease |
BEFREE |
The transcription of a reporter gene construct containing the crp2 footprint fragment crp2F (-273/+88) is hormonally regulated as determined by transfection into the human breast cancer cell line T-47D.
|
9212051 |
1997 |
|
Breast Carcinoma
|
0.020 |
Biomarker
|
disease |
BEFREE |
The transcription of a reporter gene construct containing the crp2 footprint fragment crp2F (-273/+88) is hormonally regulated as determined by transfection into the human breast cancer cell line T-47D.
|
9212051 |
1997 |
|
Epilepsy
|
0.010 |
Biomarker
|
disease |
BEFREE |
Through investigations of the function and structure of CRIP1a, new pharmacotherapies based upon the CRIP-CB<sub>1</sub> receptor interaction can be designed to treat diseases such as epilepsy, motor dysfunctions and schizophrenia.
|
31614728 |
2019 |
|
Schizophrenia
|
0.010 |
Biomarker
|
disease |
BEFREE |
Through investigations of the function and structure of CRIP1a, new pharmacotherapies based upon the CRIP-CB<sub>1</sub> receptor interaction can be designed to treat diseases such as epilepsy, motor dysfunctions and schizophrenia.
|
31614728 |
2019 |
|
Septicemia
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
CRP 2 cut-off levels of LONS group and proven sepsis group were found to be lower than the initial values.
|
30068303 |
2018 |
|
Sepsis
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
CRP 2 cut-off levels of LONS group and proven sepsis group were found to be lower than the initial values.
|
30068303 |
2018 |
|
Squamous cell carcinoma of skin
|
0.010 |
Biomarker
|
disease |
BEFREE |
HOXA9 inhibits HIF-1α-mediated glycolysis through interacting with CRIP2 to repress cutaneous squamous cell carcinoma development.
|
29662084 |
2018 |
|
Confluent and Reticulate Papillomatosis
|
0.010 |
Biomarker
|
disease |
BEFREE |
Confirming those expectations, in vitro neutralization and in vivo protection against spring viremia carp virus (SVCV) infections were demonstrated by crp2-6/CRP2-6 using crp1-7 transfected and/or CRP1-7-enriched supernatant-treated fish cells and crp2-5-injected one-cell stage embryo eggs, respectively.
|
28915434 |
2017 |
|
Thyroid carcinoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
CRIP1 (cysteine-rich intestinal protein 1) has been found in several tumor types; however, its prognostic impact and role in cellular processes, particularly in thyroid carcinoma, are still unclear.
|
29059670 |
2017 |
|
Squamous cell carcinoma of esophagus
|
0.010 |
Biomarker
|
disease |
BEFREE |
In conclusion, this study shows CRIP2 plays an important role in the development of ESCC.
|
22154084 |
2012 |
|
Vesicular Stomatitis
|
0.010 |
Biomarker
|
disease |
BEFREE |
In spite of the production of Hu IFN, murine psi-CRIP packaging cells are able to release retroviral vectors expressing Hu IFN-beta, and these amphotropic vectors can transform human MRC-5 cells and confer to these cells an enhanced resistance to vesicular stomatitis virus (VSV) infection.
|
8280795 |
1993 |